Search

Due to the insufficient stability and expensive price of commercial precious metal catalysts like Pt/C and IrO2, it is critical to study efficiently, stable oxygen reduction reaction as well as oxygen evolution reaction (ORR/OER) electrocatalysts of rechargeable Zn-air batteries. PrBa0.5Sr0.5Co1.5Fe0.5O5 (PBSCF) double perovskite was adopted due to its flexible electronic structure as well as higher electro catalytic activity. In this study, PBSCF was prepared by the citrate-EDTA method and the optimized amount of PBSCF-Pt/C composite was used as a potential ORR/OER bifunctional electrocatalyst in 0.1 M KOH. The optimized composite exhibited excellent OER intrinsic activity with an onset potential of 1.6 V and Tafel slope of 76 mV/dec under O2-saturated 0.1 M KOH. It also exhibited relatively competitive ORR activity with an onset potential of 0.9 V and half-wave potential of 0.78 V. Additionally, Zn–air battery with PBSCF composite catalyst showed relatively good stability. All these results illustrate that PBSCF-Pt/C composite is a promising bifunctional electrocatalyst for rechargeable Zn-air batteries. [ABSTRACT FROM AUTHOR]

Objective: Fibroblast growth factor 21 (FGF21) is a secreted protein that regulates body metabolism. In recent years, many observational studies have found that FGF21 is closely related to bone mineral density and osteoporosis, but the causal relationship between them is still unclear. Therefore, this study used two-sample, mediated Mendelian randomization (MR) analysis to explore the causal relationship between FGF21 and osteoporosis and bone mineral density., Methods: We conducted a two-sample, mediator MR Analysis using genetic data from publicly available genome-wide association studies (GWAS) that included genetic variants in the inflammatory cytokine FGF21, and Total body bone mineral density, Heel bone mineral density, Forearm bone mineral density, Femoral neck bone mineral density, osteoporosis. The main analysis method used was inverse variance weighting (IVW) to investigate the causal relationship between exposure and outcome. In addition, weighted median, simple median method, weighted median method and MR-Egger regression were used to supplement the explanation, and sensitivity analysis was performed to evaluate the reliability of the results., Results: MR Results showed that FGF21 overexpression reduced bone mineral density: Total body bone mineral density (OR=0.920, 95%CI: 0.876-0.966), P=0.001), Heel bone mineral density (OR=0.971, 95%CI (0.949-0.993); P=0.01), Forearm bone mineral density (OR=0.882, 95%CI(0.799-0.973); P=0.012), Femoral neck bone mineral density (OR=0.952, 95%CI(0.908-0.998), P=0.039); In addition, it also increased the risk of osteoporosis (OR=1.003, 95%CI (1.001-1.005), P=0.004). Sensitivity analysis supported the reliability of these results. The effect of FGF21 overexpression on osteoporosis may be mediated by type 2 diabetes mellitus and basal metabolic rate, with mediating effects of 14.96% and 12.21%, respectively., Conclusions: Our study suggests that the overexpression of FGF21 may lead to a decrease in bone mineral density and increase the risk of osteoporosis, and the effect of FGF21 on osteoporosis may be mediated through type 2 diabetes and basal metabolic rate. This study can provide a reference for analyzing the potential mechanism of osteoporosis and is of great significance for the prevention and treatment of osteoporosis., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Liu, Jiang, Li, Chen, Yang, Lei, He, Wang, Na, Lao, Luo, Yang and Yang.)